Increased incidence of CMV infection after allogenic bone marrow transplantation from unrelated donors but doubts about an increase in CMV-associated disease

被引：0
|
作者：
R de la Cámara
JM Fernández-Rañada
机构：
[1] Servicio de Hematologia,
[2] Hospital de la Princese,undefined
来源：
Bone Marrow Transplantation | 1997年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：181 / 181
相关论文
共 50 条
  • [41] INTERSTITIAL PNEUMONIA FOLLOWING BONE-MARROW TRANSPLANTATION - SIGNIFICANTLY LOWER INCIDENCE AFTER CMV-HYPERIMMUNOGLOBULIN, CMV-NEGATIVE THROMBOCYTE CONCENTRATES AND MODIFIED RADIATION-THERAPY
    KALHS, P
    HINTERBERGER, W
    ALTH, G
    KALLINGER, W
    KOLBABEK, H
    HOCKER, P
    SCHWARZINGER, I
    EMMINGER, W
    KOS, M
    PANZER, S
    HINTERBERGER, M
    KUNDI, M
    GADNER, H
    LECHNER, K
    [J]. ONKOLOGIE, 1987, 10 (05): : 276 - 276
  • [42] Increased risk of late CMV infection and disease in allogeneic marrow transplant recipients after ganciclovir prophylaxis is due to a lack of CMV-specific T cell responses.
    Boeckh, M
    Riddell, SR
    Cunningham, T
    Myerson, D
    Flowers, M
    Bowden, RA
    [J]. BLOOD, 1996, 88 (10) : 1195 - 1195
  • [43] Prevention of Cytomegalovirus Infection by Valaciclovir after Allogeneic Bone Marrow Transplantation from an Unrelated Donor
    Takehiko Mori
    Yoshinobu Aisa
    Takayuki Shimizu
    Tomonori Nakazato
    Rie Yamazaki
    Yasuo Ikeda
    Shinichiro Okamoto
    [J]. International Journal of Hematology, 2006, 83 : 266 - 270
  • [44] Prevention of cytomegalovirus infection by valaciclovir after allogeneic bone marrow transplantation from an unrelated donor
    Mori, T
    Aisa, Y
    Shimizu, T
    Nakazato, T
    Yamazaki, R
    Ikeda, Y
    Okamoto, S
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 83 (03) : 266 - 270
  • [45] Low incidence of CMV reactivation and infectious morbidity and mortality after nonmyeloablative haploidentical bone marrow transplantation incorporating post-transplantation cyclophosphamide.
    Symons, HJ
    Ye, XB
    Luznik, L
    Phelps, M
    Crawford, A
    Levy, MY
    Jones, RJ
    Fuchs, EJ
    [J]. BLOOD, 2005, 106 (11) : 907A - 907A
  • [46] De-Novo Belatacept Therapy is Associated with an Increased Risk of Invasive CMV Disease After Kidney Transplantation.
    Petrossian, G.
    Ortiz, J.
    Addonizio, K.
    Hsiao, A.
    Teixeira, L.
    Koizumi, N.
    James, R.
    Patel, S.
    Conti, D.
    Plews, R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 512 - 512
  • [47] GRAFT FAILURE AFTER BONE-MARROW TRANSPLANTATION FROM UNRELATED DONORS USING BUSULFAN AND CYCLOPHOSPHAMIDE FOR CONDITIONING
    MEHTA, J
    POWLES, RL
    MITCHELL, P
    REGE, K
    DELORD, C
    TRELEAVEN, J
    [J]. BONE MARROW TRANSPLANTATION, 1994, 13 (05) : 583 - 587
  • [48] No evidence of increased CMV infection and disease after autologous CD34-selected PBPC transplantation in chronic lymphoproliferative disorders
    Donelli, A
    Narni, F
    Cuoghi, A
    Luppi, M
    Sabbatini, R
    Chiodino, C
    Pietrosemoli, P
    Bartoletti, A
    Torelli, G
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S156 - S157
  • [49] Cold agglutinin disease associated with adenovirus infection after allogeneic bone marrow transplantation
    Mori, T
    Yamada, Y
    Aisa, Y
    Uemura, T
    Ishida, A
    Ikeda, Y
    Okamoto, S
    [J]. BONE MARROW TRANSPLANTATION, 2005, 36 (03) : 263 - 264
  • [50] Recovery from CMV esophagitis after allogeneic bone marrow transplantation using non-myeloablative conditioning: The role of immunosuppression
    Fiegl, M
    Gerbitz, A
    Gaeta, A
    Campe, H
    Jaeger, G
    Kolb, HJ
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2005, 34 (03) : 219 - 223
12345